Rabiner, Eugenii A.
King's College London · Invicro (United Kingdom)
16 papers on CoChatORCID 0000-0003-3612-6687
Most cited papers
- Verified
An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
Owen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism
Neuroinflammation and Neurodegeneration MechanismsPharmacological Receptor Mechanisms and Effects
Cited by 779
- Verified
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Onwordi, E. C., Halff, E. F., Whitehurst, T., Mansur, A., Cotel, M.-C., Wells, L., Creeney, H., Bonsall, D., Rogdaki, M., Shatalina, E., et al. (2020) · Nature Communications
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 243
- Verified
Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans
Owen, D. R., Narayan, N., Wells, L., Healy, L., Smyth, E., Rabiner, E. A., Galloway, D., Williams, J. B., Lehr, J., Mandhair, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism
Neuroinflammation and Neurodegeneration MechanismsPharmacological Receptor Mechanisms and Effects
Cited by 194
- Verified
Neuroinflammation in treated HIV-positive individuals: A TSPO PET study
Vera, J. H., Guo, Q., Cole, J. H., Boasso, A., Greathead, L., Kelleher, P., Rabiner, E. A., Kalk, N., Bishop, C., Gunn, R. N., et al. (2016) · Neurology
HIV Research and TreatmentNeuroinflammation and Neurodegeneration Mechanisms
Cited by 188
- Verified
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
Salem, V., Izzi‐Engbeaya, C., Coello, C., Thomas, D. B., Chambers, E. S., Comninos, A. N., Buckley, A., Win, Z., Al‐Nahhas, A., Rabiner, E. A., et al. (2016) · Diabetes, Obesity and Metabolism
Adipose Tissue and MetabolismRegulation of Appetite and Obesity
Cited by 167
- Verified
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers
Mick, I., Myers, J., Ramos, A. C., Stokes, P. R. A., Erritzoe, D., Colasanti, A., Gunn, R. N., Rabiner, E. A., Searle, G. E., Waldman, A. D., et al. (2016) · Neuropsychopharmacology
Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior
Cited by 112
- Verified
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease
Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., et al. (2022) · Science Translational Medicine
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 101
- Verified
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 100
- Verified
Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study
Haahr, M. E., Fisher, P. M., Jensen, C. G., Frokjaer, V. G., Mahon, B. M., Madsen, K., Baaré, W. F. C., Lehel, S., Norremolle, A., Rabiner, E. A., et al. (2014) · Molecular Psychiatry
Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research
Cited by 86
- Verified
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology
Treatment of Major DepressionNeuropeptides and Animal Physiology
Cited by 69
- Verified
Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy
Abanades, S., van der Aart, J., Barletta, J. A., Marzano, C., Searle, G. E., Salinas, C. A., Ahmad, J. J., Reiley, R. R., Pampols-Maso, S., Zamuner, S., et al. (2011) · Journal of Cerebral Blood Flow & Metabolism
Pharmacogenetics and Drug MetabolismMedical Imaging Techniques and Applications
Cited by 61
- Verified
Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO)
Colasanti, A., Owen, D. R., Grozeva, D., Rabiner, E. A., Matthews, P. M., Craddock, N., & Young, A. H. (2013) · Psychoneuroendocrinology
Bipolar Disorder and TreatmentGenetic Associations and Epidemiology
Cited by 55
- Verified
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Onwordi, E. C., Whitehurst, T., Mansur, A., Statton, B., Berry, A., Quinlan, M., O’Regan, D. P., Rogdaki, M., Marques, T. R., Rabiner, E. A., et al. (2021) · Translational Psychiatry
Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research
Cited by 55
- Verified
Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
Livingston, N. R., Calsolaro, V., Hinz, R., Nowell, J., Raza, S., Gentleman, S., Tyacke, R. J., Myers, J., Venkataraman, A. V., Perneczky, R., et al. (2022) · Molecular Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 44
- Verified
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [ 11 C ] PBR28 and Machine Learning Analysis
Jucaite, A., Cselényi, Z., Kreisl, W. C., Rabiner, E. A., Varrone, A., Carson, R. E., Rinne, J. O., Savage, A., Schou, M., Johnström, P., et al. (2022) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 43
- Verified
Synaptic PET imaging using [11C]UCB‐J in frontotemporal dementia
Clarke, M. T., Mansur, A., Rizzo, G., Passchier, J., Lewis, Y., Evans, K. C., Chen, L., Schwarz, A. J., Takano, A., Gunn, R. N., et al. (2021) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free